Sign In
Buy BSX
$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
Sep 10, 2020 (Heraldkeepers) --
Interventional cardiology offers with catheter-based totally technologies for the remedy of structural heart sicknesses. The...
Wall Street Breakfast: The Week Ahead
04:42am, Sunday, 06'th Sep 2020
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Stocks To Watch: Tech Reboots And Eyes On Lululemon, Peloton & GameStop
08:21am, Saturday, 05'th Sep 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
03:50pm, Friday, 04'th Sep 2020
Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
Aug 28, 2020 (Heraldkeepers) --
Interventional cardiology offers with catheter-based totally technologies for the remedy of structural heart sicknesses. The...
Daiichi Sankyo Europe GmbH (hereafter, ‘Daiichi Sankyo’) today announced that NILEMDO® (bempedoic acid) has demonstrated consistent tolerability and s
Allscripts Continuing to Lead in Physician Practice Market With Series of New Wins
12:00am, Thursday, 27'th Aug 2020
Allscripts ambulatory business has seen increasing momentum with 18 new physician practices selecting Allscripts (Nasdaq: MDRX) this year for ambulato
Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Rating Lowered by Zacks Investment Research
06:40am, Wednesday, 26'th Aug 2020
Rhythm Pharmaceuticals (NASDAQ:RYTM) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports. According t
COVID-19 Pandemic Impact on Global Interventional Spine Devices Market 2020-2024 | Technavio
12:00am, Wednesday, 26'th Aug 2020
The Global Interventional Spine Devices Market will grow by USD 2.31 bn during 2020-2024
Boston Scientific Co. (NYSE:BSX) Shares Bought by Steward Partners Investment Advisory LLC
07:30am, Saturday, 22'nd Aug 2020
Steward Partners Investment Advisory LLC raised its stake in shares of Boston Scientific Co. (NYSE:BSX) by 33.6% in the second quarter, according to its most recent 13F filing with the SEC. The fund o
Tracking David Tepper's Appaloosa Management Portfolio - Q2 2020 Update
12:32pm, Thursday, 20'th Aug 2020
David Tepper’s 13F portfolio value increased from $3.27B to $5.76B this quarter. Appaloosa added AT&T while increasing Alibaba Group Holdings during the quarter.
Boston Scientific's Voraxaze's MAA Accepted by EMA for Review
01:44pm, Tuesday, 18'th Aug 2020
Boston Scientific's (BSX) business arm's MMA for Voraxaze (glucarpidase) accepted by EMA for review.
BTG Specialty Pharmaceuticals, a division of Boston Scientific (NYSE:BSX), today announced the European Medicines Agency (EMA) has accepted for review a Marketing Authorisation Application (MAA) for V
Boston Scientific For The Long Term
12:44pm, Thursday, 13'th Aug 2020
Boston Scientific faces many headwinds in Q3 and Q4 2020 because the pandemic has dramatically curtailed its operations and reduced the demand for its products.
The
